We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$11.6B
AUM Growth
+$1.19B
Cap. Flow
+$3.23B
Cap. Flow %
27.76%
Top 10 Hldgs %
8.72%
Holding
2,732
New
694
Increased
624
Reduced
641
Closed
653

Top Buys

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$75.4M
2
ULTA icon
Ulta Beauty
ULTA
+$74.4M
3
AMZN icon
Amazon
AMZN
+$74.2M
4
MSFT icon
Microsoft
MSFT
+$64.2M
5
UNP icon
Union Pacific
UNP
+$54.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$134M
2
TSLA icon
Tesla
TSLA
+$91.1M
3
WFC icon
Wells Fargo
WFC
+$83.2M
4
PEP icon
PepsiCo
PEP
+$75.5M
5
BABA icon
Alibaba
BABA
+$73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.92%
2 Industrials 15.71%
3 Technology 15.36%
4 Financials 15.26%
5 Healthcare 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRB icon
726
H&R Block
HRB
$5.73B
$2.18M 0.02%
68,266
+60,357
+763% +$1.95M
LBTYK icon
727
Liberty Global Class C
LBTYK
$3.63B
$2.16M 0.02%
121,278
+110,227
+997% +$2.05M
KRYS icon
728
Krystal Biotech
KRYS
$9.25B
$2.15M 0.02%
+18,310
New +$1.87M
KBR icon
729
KBR
KBR
$4.68B
$2.13M 0.02%
+32,769
New +$1.95M
KR icon
730
Kroger
KR
$35.7B
$2.13M 0.02%
+45,300
New +$2.16M
NARI
731
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.13M 0.02%
36,600
+4,933
+16% +$311K
RVNC
732
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.13M 0.02%
84,000
+28,999
+53% +$903K
RGEN icon
733
Repligen
RGEN
$8.3B
$2.12M 0.02%
15,003
+10,703
+249% +$1.72M
WY icon
734
Weyerhaeuser
WY
$18.2B
$2.12M 0.02%
63,300
+47,939
+312% +$1.44M
CERE
735
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2.11M 0.02%
+66,390
New +$2.04M
HTGC icon
736
Hercules Capital
HTGC
$3.15B
$2.1M 0.02%
142,000
+141,900
+141,900% +$1.95M
KMI icon
737
Kinder Morgan
KMI
$69.9B
$2.1M 0.02%
121,912
+55,743
+84% +$947K
XBI icon
738
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.92B
$2.1M 0.02%
+551,000
New +$46.1M
CMA
739
DELISTED
Comerica
CMA
$2.09M 0.02%
49,338
-24,022
-33% -$971K
ZING
740
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
$2.09M 0.02%
200,449
+15,682
+8% +$162K
DSEY
741
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$2.09M 0.02%
+248,689
New +$2.05M
MXL icon
742
MaxLinear
MXL
$6.6B
$2.08M 0.02%
65,900
+5,800
+10% +$168K
BILL icon
743
BILL Holdings
BILL
$4.7B
$2.08M 0.02%
17,788
-51,636
-74% -$4.91M
GRCL
744
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$2.07M 0.02%
543,687
-69,492
-11% -$195K
AIT icon
745
Applied Industrial Technologies
AIT
$13B
$2.07M 0.02%
14,292
+11,184
+360% +$1.49M
DB icon
746
Deutsche Bank
DB
$69.8B
$2.05M 0.02%
194,600
+176,200
+958% +$1.86M
AY
747
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$2.05M 0.02%
+87,300
New +$2.24M
NTLA icon
748
Intellia Therapeutics
NTLA
$1.5B
$2.04M 0.02%
50,078
+12,851
+35% +$521K
CMG icon
749
Chipotle Mexican Grill
CMG
$42.8B
$2.03M 0.02%
47,450
+12,450
+36% +$492K
ICLR icon
750
Icon
ICLR
$12.2B
$2.03M 0.02%
8,100
+2,964
+58% +$629K
28 29
30
31 32

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Schonfeld Strategic Advisors held 2,732 positions worth $11.6B, up 11% from $10.4B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Schonfeld Strategic Advisors deployed $3.23B of net new capital in Q2 2023, opening 694 new positions and adding to 624 existing holdings. Its largest new stake was Ulta Beauty: 151,799 shares worth $71.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Visa, an estimated $134M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2023 buy was Ulta Beauty: 151,799 shares worth $71.4M.
  • Schonfeld Strategic Advisors added most to Sherwin-Williams in Q2 2023, an estimated $75.4M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2023 reduction was Visa, cutting an estimated $134M.
  • Schonfeld Strategic Advisors fully exited Alibaba in Q2 2023, selling an estimated $73M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 8.7% of its $11.6B portfolio in Q2 2023.
  • Schonfeld Strategic Advisors opened 694 new positions and closed 653 in Q2 2023.
  • Schonfeld Strategic Advisors's portfolio value rose 11% quarter-over-quarter to $11.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.